Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study
Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study
OBJECTIVES: We evaluated clinical features, treatment practices and early outcome in a multicentre cohort of children with cerebral sinovenous thrombosis (CSVT).
METHODS: Children with CSVT from 10 countries were enrolled from January 2003 to July 2007 in the International Paediatric Stroke Study. We analysed clinical symptoms, underlying conditions, antithrombotic treatment and neurological outcome at hospital discharge in 170 children.
RESULTS: Of 170 children enrolled, 60% were male; median age 7.2 years (IQR 2.9-12.4). Headache, altered consciousness, focal deficits and seizures were common presenting clinical features. Infarction affected 37% and intracranial haemorrhage 31%. Risk factors included chronic disease in 50%; acute systemic illness or head/neck disorders 41%; prothrombotic state 20% and other haematological abnormality 19%. Discharge neurological status was normal in 48%, abnormal in 43% and unknown in 5%. Antithrombotic therapy was common, most often low molecular weight heparin was common, with significant regional variation in treatment practices. Mortality was low (4%) and was associated with no anticoagulation but not underlying chronic disease, anatomic extent of thrombosis or intracranial haemorrhage. Abnormal neurological status at discharge or death was associated with decreased level of consciousness at presentation and the presence of an identified prothrombotic state.
CONCLUSIONS: Our study extends the observations of previously published smaller studies in children with CSVT that this is a morbid disease with diverse underlying causes and risk factors. Divergent treatment practices among highly specialised centres as well as limited data on treatment efficacy and safety suggest that further study of this condition is warranted.
Child, Child, Preschool, Female, Fibrinolytic Agents, Humans, Intracranial Thrombosis, Male, Risk Factors, Stroke, Treatment Outcome, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
174-179
Ichord, R.N.
d3cb64eb-0dab-4e05-bbb6-f0ff9bbdcea8
Benedict, S.L.
2fc88a9d-3f13-4458-a9fa-d5207b01f776
Chan, A.K.
0d7bc0b4-b955-4bd5-bfda-ff541a4e69fa
Kirkham, F.J.
1dfbc0d5-aebe-4439-9fb2-dac6503bcd58
Nowak-Göttl, U.
7f2e4b9a-3d08-4bf1-8207-6bc7603f7e10
International Paediatric Stroke Study Group
February 2015
Ichord, R.N.
d3cb64eb-0dab-4e05-bbb6-f0ff9bbdcea8
Benedict, S.L.
2fc88a9d-3f13-4458-a9fa-d5207b01f776
Chan, A.K.
0d7bc0b4-b955-4bd5-bfda-ff541a4e69fa
Kirkham, F.J.
1dfbc0d5-aebe-4439-9fb2-dac6503bcd58
Nowak-Göttl, U.
7f2e4b9a-3d08-4bf1-8207-6bc7603f7e10
Ichord, R.N., Benedict, S.L., Chan, A.K., Kirkham, F.J. and Nowak-Göttl, U.
,
International Paediatric Stroke Study Group
(2015)
Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study.
Archives of Disease in Childhood, 100 (2), .
(doi:10.1136/archdischild-2014-306382).
Abstract
OBJECTIVES: We evaluated clinical features, treatment practices and early outcome in a multicentre cohort of children with cerebral sinovenous thrombosis (CSVT).
METHODS: Children with CSVT from 10 countries were enrolled from January 2003 to July 2007 in the International Paediatric Stroke Study. We analysed clinical symptoms, underlying conditions, antithrombotic treatment and neurological outcome at hospital discharge in 170 children.
RESULTS: Of 170 children enrolled, 60% were male; median age 7.2 years (IQR 2.9-12.4). Headache, altered consciousness, focal deficits and seizures were common presenting clinical features. Infarction affected 37% and intracranial haemorrhage 31%. Risk factors included chronic disease in 50%; acute systemic illness or head/neck disorders 41%; prothrombotic state 20% and other haematological abnormality 19%. Discharge neurological status was normal in 48%, abnormal in 43% and unknown in 5%. Antithrombotic therapy was common, most often low molecular weight heparin was common, with significant regional variation in treatment practices. Mortality was low (4%) and was associated with no anticoagulation but not underlying chronic disease, anatomic extent of thrombosis or intracranial haemorrhage. Abnormal neurological status at discharge or death was associated with decreased level of consciousness at presentation and the presence of an identified prothrombotic state.
CONCLUSIONS: Our study extends the observations of previously published smaller studies in children with CSVT that this is a morbid disease with diverse underlying causes and risk factors. Divergent treatment practices among highly specialised centres as well as limited data on treatment efficacy and safety suggest that further study of this condition is warranted.
This record has no associated files available for download.
More information
e-pub ahead of print date: 20 January 2015
Published date: February 2015
Keywords:
Child, Child, Preschool, Female, Fibrinolytic Agents, Humans, Intracranial Thrombosis, Male, Risk Factors, Stroke, Treatment Outcome, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
Identifiers
Local EPrints ID: 420597
URI: http://eprints.soton.ac.uk/id/eprint/420597
ISSN: 0003-9888
PURE UUID: d4430b1e-1b65-4003-9c01-8e91554c5618
Catalogue record
Date deposited: 10 May 2018 16:30
Last modified: 16 Mar 2024 03:22
Export record
Altmetrics
Contributors
Author:
R.N. Ichord
Author:
S.L. Benedict
Author:
A.K. Chan
Author:
U. Nowak-Göttl
Corporate Author: International Paediatric Stroke Study Group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics